Answers are grounded in this paper and cite their sources.
Findings reveal Ccr2 dependence of bone marrow-derived TR-MC in rheumatoid arthritis, indicating adaptive immunity involvement.
Description Monocytes are critical for rheumatoid arthritis (RA), but their depletion does not rescue the disease in mouse models. We identified tissue-resident monocyte lineage cells (TR-MC) as essential for acute RA-like disease in mice, though their ontogeny and functions remain unclear. Here, we identified bone marrow (BM)-derived and long-lived TR-MC in CD45.1 → CD45.2 B6 bone marrow chimera (BMC) and parabiosis mice. CITE-seq of BMC validated the heterogeneity and further classified TR-MC into one BM-derived and two long-lived TR-MC subsets, marked by Ccr2, Cd163, and Cx3cr1, with gene ontology showing long-lived TR-MC are enriched in homeostasis processes, while BM-derived TR-MC are linked to adaptive immunity. Comparing the numbers of TR-MC subsets within reciprocal Ccr2-/- & CD45.1 BMC and parabiosis pairs, BM-derived TR-MC were significantly reduced in Ccr2-/- → CD45.1 BMC and Ccr2-/- pair, indicating their Ccr2 dependence. On day 7 post clodronate liposome treatment, BM-derived TR-MC upregulated Plac8 and Il1b expression, indicating they were newly replenished from circulation and responsive to synovial niche disruption. During the development of RA-like arthritis in mice, CITE-seq revealed novel BM-derived TR-MC at the peak and plateau stages. At these stages, BM-derived TR-MC outnumbered long-lived TR-MC, with subset ratios returning to steady-state levels during recovery. These findings highlight the heterogeneity of TR-MC and their central role in arthritis development.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: